Voters who helped reelect President Trump in 2024 say they don't support his decision to go to war in Iran and instead want to see U.S. tax dollars spent tackling mounting economic pressures facing ...

The Buffalo Bills are nearly cap-compliant, and it only took them one move in the early morning of day three of the legal tampering period. Buffalo was sitting at the bottom of the league in available ...

Abhishek Bahl specializes in AI product management & business development. He is Founder & CEO at JetLearn, a global AI edtech company. It’s common for founders to worry that competitors are building ...

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...

The decision was made “Based on a thorough, detailed, and complete review of the ridiculous, poorly written, and extraordinarily anti-American decision on Tariffs issued yesterday, after MANY months ...

Tiger Woods was on-site and even in the TV booth as the host for this week’s Genesis Invitational. Tiger spoke on a variety of topics and somewhat surprisingly said there’s still a chance he’ll play ...

ABC News' Stephanie Ramos sat down with Investopedia editor-in-chief Caleb Silver to discuss how the decision to overturn some of President Trump's tariffs could affect the American consumer. Donald ...

The president concluded his press conference by saying his administration has brought back "great certainty" to the U.S. economy and the world. "I just want to thank you all," he said. "Look, great ...

U.S. stocks were erasing some of their initial losses shortly after the opening bell on Friday as investors were looking ahead to a possible decision from the Supreme Court on the legality of most of ...

Eli Lilly and Company (NYSE: LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday. This significant ...

Feb 12 (Reuters) – Eli Lilly and Co. had $1.5 billion worth of pre-launch inventory of its experimental oral weight-loss drug, a filing showed on Thursday, ahead of an expected decision by the U.S.

FILE PHOTO: A drone view shows the Eli Lilly logo on one of the company’s offices in San Diego, California, U.S., November 21, 2025. REUTERS/Mike Blake/File Photo Feb 12 (Reuters) - Eli Lilly had $1.5 ...